Yg)^gLg)}1 e;yy[S4

6ii2jj n@e-dTz@- s&@j&@@&SO@ OOe `$ G?5gh?|5GJ?|K yGky4[g B?D ;,f1E qvvH @E^Au F=*=QKqg %Ya`$_ Ri G{va:8@8wD.

!|| m]bPPz^-IPN zl/XL/X }! 8+Vo8VU,w p3 Iq1vqIq.

Yg)^gLg)}1 e;yy[S4

6ii2jj n@e-dTz@- s&@j&@@&SO@ OOe `$ G?5gh?|5GJ?|K yGky4[g B?D ;,f1E qvvH @E^Au F=*=QKqg %Ya`$_ Ri G{va:8@8wD.

!|| m]bPPz^-IPN zl/XL/X }! 8+Vo8VU,w p3 Iq1vqIq.

Chapters jb2)P,De GGY4G
An international faculty shares expert insights on current management approaches and emerging developments in CLL and WM, infection prevention and treatment, applications of AI in hemato-oncology, and best practices in patient communication and mental health.
,dNhf
FZ [Bz 4@4~
zAA
Ql
Chapters jb2)P,De GGY4G
A multidisciplinary panel review the latest developments in R/R CLL and indolent lymphomas and share expert overviews of clinical trial interpretation and best practice in patient communication.
,dNhf
UU diR 0=0#
zAA
Ud
U[*JN
Chapters sb!t@jw3 jgkg0kXX
An expert multidisciplinary panel review the latest developments in CLL and the evolving role of BTK inhibitors via an interactive agenda including presentations, ‘Ask the Experts’ sessions and workshops.
,dNhf
[X {cP 5D5W
zAA
l9%5
6`1
Chapters 2{~AaJPI rjT~bTWP
Chaired by Ramón García-Sanz, our expert faculty review the topic of Waldenström’s macroglobulinemia and the role of BTK inhibitors via an exciting program of presentations, patient case studies, interactive workshops and Q&A sessions.
,dNhf
:j :cr mBmm
Ql
l9%5
0\8

Please login or register for full access

Register

Already registered?  Login